Olympus Corp shares slide nearly 14% on FY guidance cut

Olympus Corp shares plummeted nearly 14% on the Tokyo Stock Exchange on Friday, October 27, 2023, after the medical device manufacturer significantly cut its fiscal year guidance due to persistent supply chain disruptions and weakening demand in its key endoscopy division. The Tokyo-based company, known for its cameras and medical equipment, revised its full-year profit forecast down by approximately 30%, citing unexpected challenges in component procurement and slower-than-expected recovery in hospital procedures following the pandemic. Analysts had expected the company to maintain its previous guidance despite global economic uncertainties, with many institutional investors holding significant positions in the stock. The sharp decline in share value represents one of the most significant single-day drops for Olympus in the past year, with trading volume exceeding the three-month average as investors reacted to the disappointing outlook. The guidance cut comes at a challenging time for Olympus as it faces increasing competition from both established medical technology firms and emerging startups in the minimally invasive surgery space.